Pediatrics Doctors in Newport, VT Accepting Medicare

3 Pediatrics doctors found. Showing 1 - 3

Dr. Thomas Addis Emmet Moseley Iii, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 121 Medical Village Dr, Newport Pediatrics And Adolescent Medicine Pllc, Newport, VT 05855 Phone: 802-334-5929

Dr. Alexandra Bannach, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 121 Medical Village Dr, Newport, VT 05855 Phone: 802-334-5929    Fax: 802-487-1051

Sarah L Mcauliff, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 121 Medical Village Dr, Newport, VT 05855 Phone: 802-334-5929

News Archive

Eggshells can enhance growth of new, strong bones

Eggshells can enhance the growth of new, strong bones needed in medical procedures, a team of UMass Lowell researchers has discovered.

Toolkit for measuring tranquillity

Bradford researchers have developed a toolkit for measuring tranquillity that could enable neglected or overlooked urban parks to flourish and become a haven for stressed city workers.

Researchers develop an index scale to help physicians predict a patient's risk of dying from COPD

Researchers have developed an index scale to help physicians predict a patient's risk of dying from chronic obstructive pulmonary disease (COPD). The ADO index can help physicians assess the severity of a patient's illness to determine the appropriate level of treatment. COPD, which comprises emphysema and chronic bronchitis, is a major public health problem and it is the fourth leading cause of death in the U.S. The study of the ADO index is published in the August 29 edition of the Lancet.

Novo Nordisk to appeal against ruling in repaglinide combination patent case

Today, Novo Nordisk announced that Judge Avern Cohn of the US District Court for the Eastern District of Michigan issued an adverse ruling in a patent litigation case regarding Novo Nordisk's US Patent No. 6,677,358. The district court ruled that the patent, which covers the combination use of repaglinide and metformin for the treatment of type 2 diabetes, is invalid and unenforceable.

Read more Medical News

› Verified 8 days ago